Page 1

Curaleaf Holdings , Inc. Investor Relations CURALEAF REPORTS RECORD SECOND QUARTER 2021 RESULTS - Second quarter 2021 Revenue ( ¹ ) of $ 312 million , up 20 % sequentially and 166 % YoY - Second quarter 2021 Adjusted EBITDA margin of 28 % on core U.S. operations , up 400 bps QoQ - Second quarter 2021 Adjusted EBITDA ( ¹ ) of $ 84 million , up 35 % sequentially and 201 % YoY - Closed acquisition of EMMAC , Europe's largest vertically integrated cannabis company WAKEFIELD , Mass . , Aug. 9 , 2021 / PRNewswire / -- Curaleaf Holdings , Inc. ( CSE : CURA ) ( OTCQX : CURLF ) ( " Curaleaf " or the " Company " ) , a leading international provider of consumer products in cannabis , today reported its financial and operating results for the second quarter ended June 30 , 2021. All financial information is provided in U.S. dollars unless otherwise indicated . Second Quarter 2021 Financial Highlights ( $ thousands , except per share amounts ) Total Revenue Gross profit before impact of biological assets Gross profit on cannabis sales ( ¹ ) ( 2 ) Gross margin on cannabis sales ( 1 ) ( 2 ) Adjusted EBITDA ( ¹ ) $ Net income ( loss ) attributable to Curaleaf Holdings Inc. $ Net income ( loss ) per share - basic and diluted Q2 2021 $ 312,205 $ 260,320 $ 155,238 $ 128,467 154,527 $ 28,030 49.6 % U.S. Live Call : 1 ( 888 ) 317 6003 International Live Call ( Toll ) : 1 ( 412 ) 317 6061 Canadian Live Call : 1 ( 866 ) 284 3684 Q1 2021 84,372 $ ( 7,240 ) $ ( 0.01 ) $ 49.3 % 62,625 ( 17,211 ) ( 0.03 ) % qoq Change 20 % $ 117,480 21 % $ 60,636 42,735 Earnings Call : Monday , August 9 , 2021 , at 5:00 P.M. ET Conference ID # is 1222509 Replay ID # is 10158196 21 % 35 % $ $ $ Q2 2020 42.9 % 27,994 ( 2,029 ) ( 0.00 ) % yoy Change U.S. Replay : 1 ( 877 ) 344 7529 International Replay ( Toll ) : 1 ( 412 ) 317 0088 Canadian Replay : 1 ( 855 ) 669 9658 The teleconference will be available for replay starting at approximately 7:00 P.M. ET on August 9 , 2021 and will end at 7:00 P.M. ET on August 16 , 2021 166 % ( 1 ) See " Non - IFRS Financial and Performance Measures " below for more information regarding Curaleaf's use of Non IFRS financial measures and other reconciliations . ( 2 ) Cannabis sales excludes Management Fee Income 156 % 262 % 201 % Boris Jordan , Executive Chairman of Curaleaf commented , " July saw the introduction of the most comprehensive cannabis reform ever proposed at the Federal level . Combined with U.S. state - level liberalization and the significant investments we are making in cultivation , production and distribution , Curaleaf is creating a strong foundation for future growth . Nearer - term this includes the expansion of New York , New Jersey and Connecticut from medical to adult - use markets representing a potential new $ 8 billion annual addressable market opportunity . Longer - term , our acquisition of EMMAC and establishment of Curaleaf International this quarter marks our entry into Greater Europe , with a population of 750 million representing a potential market size twice that of the United States . " Joe Bayern , Chief Executive Officer of Curaleaf stated , " Curaleaf continues to make excellent progress in terms of executing our U.S. strategy to achieve unrivaled scale and reach , and our record second quarter results